In the last trading session, 1.05 million Abeona Therapeutics Inc (NASDAQ:ABEO) shares changed hands as the company’s beta touched 1.69. With the company’s per share price at $5.33 changed hands at -$0.06 or -1.11% during last session, the market valuation stood at $260.10M. ABEO’s last price was a discount, traded about -27.2% off its 52-week high of $6.78. The share price had its 52-week low at $3.05, which suggests the last value was 42.78% up since then. When we look at Abeona Therapeutics Inc’s average trading volume, we note the 10-day average is 1.13 million shares, with the 3-month average coming to 555.50K.
Analysts gave the Abeona Therapeutics Inc (ABEO) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended ABEO as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight. Abeona Therapeutics Inc’s EPS for the current quarter is expected to be -0.36.
Abeona Therapeutics Inc (NASDAQ:ABEO) trade information
Instantly ABEO was in red as seen at the end of in last trading. With action 10.12%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -4.31%, with the 5-day performance at 10.12% in the green. However, in the 30-day time frame, Abeona Therapeutics Inc (NASDAQ:ABEO) is 6.81% up. Looking at the short shares, we see there were 2.76 million shares sold at short interest cover period of 3.57 days.
The consensus price target for the stock as assigned by Wall Street analysts is 16, meaning bulls need an upside of 66.69% from its current market value. According to analyst projections, ABEO’s forecast low is 16 with 16 as the target high. To hit the forecast high, the stock’s price needs a -200.19% plunge from its current level, while the stock would need to soar -200.19% for it to hit the projected low.
According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. The estimates for the next quarter sales put growth at 0.00%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 47.21%. The 2025 estimates are for Abeona Therapeutics Inc earnings to increase by 20.86%, but the outlook for the next 5-year period is at 53.58% per year.
ABEO Dividends
Abeona Therapeutics Inc is expected to release its next quarterly earnings report on 2025-Mar-19.
Abeona Therapeutics Inc (NASDAQ:ABEO)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 6.59% of Abeona Therapeutics Inc shares while 68.18% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 72.99%.
Among Mutual Funds, the top two as of Dec 31, 2024 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . With 1.23 shares estimated at $6.57 million under it, the former controlled 2.53% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held about 1.39% of the shares, roughly 678.1 shares worth around $3.61 million.
